Imaging more, changing nothing: Are there predictors of unchanged management after [18F]PSMA-1007 PET/CT in primary staging of high-risk prostate cancer?
Authors:
Open Access
- 23 October 2026
- journal article
- Published by Elsevier in The EANM Journal
- Vol. 5
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2026 Update: Treatment of Relapsing and Metastatic Prostate CancerEuropean Urology, 2026
- EAU–EANM–ESTRO–ESUR–ISUP–SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentEuropean Urology, 2026
- Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)European Journal of Nuclear Medicine and Molecular Imaging, 2023
- PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2023
- Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensusRadiotherapy and Oncology, 2022
- Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentRadiotherapy and Oncology, 2020
- Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2European Urology, 2019
- 68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?Clinical Genitourinary Cancer, 2018
- The EANM practice guidelines for bone scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- ESUR prostate MR guidelines 2012European Radiology, 2012